Number of the records: 1  

Design, synthesis, and antiproliferative effect of 2,9-bis[4-(pyridinylalkylaminomethyl)phenyl]-1,10-phenanthroline derivatives on human leukemic cells by targeting G-quadruplex

  1. 1.
    0542180 - BFÚ 2022 RIV DE eng J - Journal Article
    Guillon, J. - Denevault-Sabourin, C. - Chevret, E. - Brachet-Botineau, M. - Milano, V. - Guedin-Beaurepaire, A. - Moreau, S. - Ronga, L. - Savrimoutou, S. - Rubio, S. - Ferrer, J. - Lamarche, J. - Mergny, Jean-Louis - Viaud-Massuard, M.C. - Ranz, M. - Largy, E. - Gabelica, V. - Rosu, F. - Gouilleux, F. - Desplat, V.
    Design, synthesis, and antiproliferative effect of 2,9-bis[4-(pyridinylalkylaminomethyl)phenyl]-1,10-phenanthroline derivatives on human leukemic cells by targeting G-quadruplex.
    Archiv der Pharmazie. Roč. 354, č. 8 (2021), č. článku e2000450. ISSN 0365-6233. E-ISSN 1521-4184
    Institutional support: RVO:68081707
    Keywords : 1, 10-phenanthroline * antiproliferative activity * FRET melting * G4 ligands * G-quadruplex
    OECD category: Pharmacology and pharmacy
    Impact factor: 4.613, year: 2021
    Method of publishing: Limited access
    https://onlinelibrary.wiley.com/doi/10.1002/ardp.202000450

    Current multiagent chemotherapy regimens have improved the cure rate in acute leukemia patients, but they are highly toxic and poorly efficient in relapsed patients. To improve the treatment approaches, new specific molecules are needed. The G-quadruplexes (G4s), which are noncanonical nucleic acid structures found in specific guanine-rich DNA or RNA, are involved in many cellular events, including control of gene expression. G4s are considered as targets for the development of anticancer agents. Heterocyclic molecules are well known to target and stabilize G4 structures. Thus, a new series of 2,9-bis[(substituted-aminomethyl)phenyl]-1,10-phenanthroline derivatives (1a-i) was designed, synthesized, and evaluated against five human myeloid leukemia cell lines (K562, KU812, MV4-11, HL60, and U937). Their ability to stabilize various oncogene promoter G4 structures (c-MYC, BCL-2, and K-RAS) as well as the telomeric G4 was also determined through the fluorescence resonance energy transfer melting assay and native mass spectrometry. In addition, the more bioactive ligands 1g-i were tested for telomerase activity in HuT78 and MV4-11 protein extracts.
    Permanent Link: http://hdl.handle.net/11104/0319657

     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.